Inventor · disambiguated record
Shaun M. Lippow
Also filed as: LIPPOW SHAUN · LIPPOW SHAUN M
17 granted patents·17 pending applications·70 citations·filing 2008–2024
92Inventor score
Top patents by PatentIndex Score
34 records- 0195US9238080B2Bi-specific fusion proteinsNIELSEN ULRIK·Filed 2011·Granted Jan 19, 2016·29 cites·21 claims
- 0294US10988547B2Bi-specific fusion proteinsSILVER CREEK PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·6 cites·7 claims
- 0394US9718892B2Method of treating myocardial infarction by administering a bi-specific fusion proteinMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Aug 1, 2017·12 cites·10 claims
- 0493US10407512B2Bi-specific fusion proteinsSILVER CREEK PHARMACEUTICALS INC·Filed 2017·Granted Sep 10, 2019·9 cites·8 claims
- 0590US11814443B2Bi-specific fusion proteinsSILVER CREEK PHARMACEUTICALS INC·Filed 2021·Granted Nov 14, 2023·1 cites·20 claims
- 0689US2024101713A1Bi-Specific Fusion ProteinsSILVER CREEK PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0786US11472885B2Antibodies that bind tumor tissue for diagnosis and therapyATRECA INC·Filed 2020·Granted Oct 18, 2022·3 cites·36 claims
- 0879US12162945B2EPHA2 antibodiesIMMUNOME INC·Filed 2022·Granted Dec 10, 2024·1 cites·5 claims
- 0975US8748146B2Engineered nucleases and their uses for nucleic acid assemblyLIPPOW SHAUN·Filed 2008·Granted Jun 10, 2014·4 cites·12 claims
- 1075US8404465B2Biological synthesis of 6-aminocaproic acid from carbohydrate feedstocksBAYNES BRIAN M·Filed 2010·Granted Mar 26, 2013·1 cites·6 claims
- 1173US8722586B2Cell surface display, screening and production of proteins of interestRAKESTRAW JAMES A·Filed 2009·Granted May 13, 2014·2 cites·19 claims
- 1272US11104718B2Red blood cell targeted factor VIII and method of using the sameBAYER HEALTHCARE LLC·Filed 2017·Granted Aug 31, 2021·1 cites·1 claims
- 1371US2022155319A1Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2022·Application pending·0 cites
- 1466US9102961B2Biological synthesis of difunctional hexanes and pentanes from carbohydrate feedstocksCELEXION LLC·Filed 2014·Granted Aug 11, 2015·0 cites·20 claims
- 1566US2025051464A1Epha2 antibodiesIMMUNOME INC·Filed 2024·Application pending·0 cites
- 1665US8709980B2Cell surface display, screening and production of proteins of interestRAKESTRAW JAMES A·Filed 2008·Granted Apr 29, 2014·1 cites·7 claims
- 1763US11655290B2Anti-CSP antibodiesATRECA INC·Filed 2022·Granted May 23, 2023·0 cites·31 claims
- 1863US8722385B2Biological synthesis of difunctional hexanes and pentanes from carbohydrate feedstocksBAYNES BRIAN M·Filed 2012·Granted May 13, 2014·0 cites·8 claims
- 1962US10620219B2Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2017·Granted Apr 14, 2020·0 cites·7 claims
- 2062US9645146B2Cell surface display, screening and production of proteins of interestAGENUS INC·Filed 2014·Granted May 9, 2017·0 cites·17 claims
- 2162US2023140035A1Antibodies that bind tumor tissue for diagnosis and therapyATRECA INC·Filed 2022·Application pending·0 cites
- 2261US2017261506A1Cell Surface Display, Screening and Production of Proteins of InterestAGENUS INC·Filed 2017·Application pending·0 cites
- 2360US2011160071A1Novel Proteins and Methods for Designing the SameBAYNES BRIAN M·Filed 2009·Application pending·0 cites
- 2458US2022089685A1Red blood cell targeted factor viii and method of using the sameBAYER HEALTHCARE LLC·Filed 2021·Application pending·0 cites
- 2557US2019112586A1Engineered Nucleases and Their Uses for Nucleic Acid AssemblyAGENUS INC·Filed 2018·Application pending·0 cites
- 2657US2023381130A1Antibody scaffold structureATRECA INC·Filed 2023·Application pending·0 cites
- 2757US2020355698A1Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2020·Application pending·0 cites
- 2856US2015252392A1Biological synthesis of difunctional hexanes and pentanes from carbohydrate feedstocksCELEXION LLC·Filed 2015·Application pending·0 cites
- 2955US2015024464A1Engineered nucleases and their uses for nucleic acid assemblyCELEXION LLC·Filed 2014·Application pending·0 cites
- 3051US2024301038A1Antibodies to sars-cov-2ATRECA INC·Filed 2022·Application pending·0 cites
- 3148US2021040185A1Anti-hiv antibodiesATRECA INC·Filed 2020·Application pending·0 cites
- 3247US2021040184A1Anti-hiv antibodiesATRECA INC·Filed 2020·Application pending·0 cites
- 3346US2024025971A1Antibodies to coronavirus sars-cov-2ATRECA INC·Filed 2021·Application pending·0 cites
- 3446US2022195023A1Anti-csp antibody variantsATRECA INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →